MX2023000105A - Metodos para diagnosticar patogenos respiratorios y predecir los resultados relacionados con el covid-19. - Google Patents

Metodos para diagnosticar patogenos respiratorios y predecir los resultados relacionados con el covid-19.

Info

Publication number
MX2023000105A
MX2023000105A MX2023000105A MX2023000105A MX2023000105A MX 2023000105 A MX2023000105 A MX 2023000105A MX 2023000105 A MX2023000105 A MX 2023000105A MX 2023000105 A MX2023000105 A MX 2023000105A MX 2023000105 A MX2023000105 A MX 2023000105A
Authority
MX
Mexico
Prior art keywords
covid
predicting
methods
respiratory pathogens
related outcomes
Prior art date
Application number
MX2023000105A
Other languages
English (en)
Inventor
Kathleen Barnes
Ivana Yang
Christopher Gignoux
Rasika Mathias
Paul Norman
Alem Taye
Rishi Porecha
Bret Barnes
Brett Peterson
Original Assignee
Univ Colorado Regents
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Colorado Regents filed Critical Univ Colorado Regents
Publication of MX2023000105A publication Critical patent/MX2023000105A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701Specific hybridization probes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/6858Allele-specific amplification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/118Prognosis of disease development
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/154Methylation markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)

Abstract

El concepto de la invención proporciona una plataforma basada en la metilación del ADN, y algoritmos de aprendizaje automático, para diagnosticar patógenos respiratorios que incluyen SARS-CoV-2 y predecir los resultados relacionados con el COVID-19, y métodos para usarlos, tales como identificar la presencia de una infección viral, tal como una infección por SARS-CoV-2, determinar si un sujeto tiene COVID-19, y/o si un sujeto con COVID-19 tiene probabilidad de desarrollar el síndrome de dificultad respiratoria aguda o síndrome inflamatorio multisistema en niños.
MX2023000105A 2020-06-23 2021-06-23 Metodos para diagnosticar patogenos respiratorios y predecir los resultados relacionados con el covid-19. MX2023000105A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063042669P 2020-06-23 2020-06-23
PCT/US2021/038763 WO2021262894A1 (en) 2020-06-23 2021-06-23 Methods for diagnosing respiratory pathogens and predicting covid-19 related outcomes

Publications (1)

Publication Number Publication Date
MX2023000105A true MX2023000105A (es) 2023-04-25

Family

ID=79281779

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2023000105A MX2023000105A (es) 2020-06-23 2021-06-23 Metodos para diagnosticar patogenos respiratorios y predecir los resultados relacionados con el covid-19.

Country Status (10)

Country Link
US (1) US20240093318A1 (es)
EP (1) EP4168593A1 (es)
JP (1) JP2023532444A (es)
KR (1) KR20230038486A (es)
CN (1) CN116096920A (es)
AU (1) AU2021297245A1 (es)
BR (1) BR112022026509A2 (es)
CA (1) CA3184128A1 (es)
MX (1) MX2023000105A (es)
WO (1) WO2021262894A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4303326A1 (fr) * 2022-07-06 2024-01-10 Biomérieux Determination du risque de deces d'un sujet infecte par un virus respiratoire par mesure du niveau d'expression du gene oas2
WO2024008955A1 (en) * 2022-07-08 2024-01-11 Age Labs As Method of screening for severe covid-19 susceptibility

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1297182A2 (en) * 2000-06-30 2003-04-02 Epigenomics AG Diagnosis of diseases associated with cell signalling
WO2018161031A1 (en) * 2017-03-02 2018-09-07 Youhealth Biotech, Limited Methylation markers for diagnosing hepatocellular carcinoma and lung cancer

Also Published As

Publication number Publication date
BR112022026509A2 (pt) 2023-03-07
JP2023532444A (ja) 2023-07-28
CN116096920A (zh) 2023-05-09
EP4168593A1 (en) 2023-04-26
US20240093318A1 (en) 2024-03-21
WO2021262894A1 (en) 2021-12-30
KR20230038486A (ko) 2023-03-20
AU2021297245A1 (en) 2023-02-02
CA3184128A1 (en) 2021-12-30

Similar Documents

Publication Publication Date Title
MX2023000105A (es) Metodos para diagnosticar patogenos respiratorios y predecir los resultados relacionados con el covid-19.
EP2576833A4 (en) METHOD AND DEVICE FOR THE POINT-OF-CARE DETECTION OF NUCLEIC ACID IN A SAMPLE
IN2014DN06795A (es)
GB2499519B (en) User presence detection and event discovery
BR112017002876A2 (pt) método de detecção de vírus do computador e sistema deste
MY181302A (en) Method and a monitoring system for monitoring gas stunning of birds
CL2019002787A1 (es) Método y sistema para la evaluación del aliento de un paciente para determinar la concentración de diversos. (divisional solicitud 201800570)
JP2011210179A5 (es)
EA201691605A1 (ru) Стеклянный лист с кодом идентификации
CR20140188A (es) Extractor y método de artículo moldeado
WO2016203267A3 (en) Diagnosis and treatment of infectious disease
CA3056911A1 (en) Methods for diagnosing and treating inflammatory bowel disease
WO2013028544A3 (en) Compositions and methods for detecting and discriminating between yeast or mold
GB2568854A (en) Methods for automated controversy detection of content
IN2013CH01324A (es)
MY176888A (en) Method for detection of target analyte(s)
TW201613017A (en) Method for rejecting tuning disturbances to improve lamp failure prediction quality in thermal processes
Grzebyk et al. Phenotypic evaluation of hydrophobicity and the ability to produce biofilm in coagulase-negative staphylococci isolated from infected very-low-birthweight newborns
董奎勇 et al. A worsted yarn virtual production system based on BP neural network
MX2022011811A (es) Metodos y tratamiento con exceso de light libre.
孙胜男 The analysis of correlation between serum procalcitonin concentration and microbial infectionsin patients with sepsis
MX2017004816A (es) Métodos para predecir resultados clínicos en sujetos afectados con colitis ulcerosa.
O'Horo et al. C45 MECHANICAL VENTILATION: The Clinical Pulmonary Infection Score And Ventilator Associated Events
Gunathilaka et al. MOLECULAR BASED METHOD FOR THE DETECTION OF Salmonella IN MEAT PRODUCTS
MX2015016721A (es) Metodo de pronostico en cancer de mama.